{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:35:29Z","timestamp":1792683329518,"version":"4.5.0"},"reference-count":191,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>ATP-binding cassette (ABC) transporters play a crucial role in multidrug resistance (MDR) of cancers. They function as efflux pumps, resulting in limited effectiveness or even failure of therapy. Increasing evidence suggests that ABC transporters are also involved in tumor initiation, progression, and metastasis. Tumors frequently show multiple genetic and epigenetic abnormalities, including changes in histone modification and DNA methylation. Alterations in the DNA methylation status of ABC transporters have been reported for a variety of cancer types. In this review, we outline the current knowledge of DNA methylation of ABC transporters in cancer. We give a brief introduction to structure, function, and gene regulation of ABC transporters that have already been investigated for their DNA methylation status in cancer. After giving an overview of the applied methodologies and the CpGs analyzed, we summarize and discuss the findings on aberrant DNA methylation of ABC transporters by cancer types. We conclude our review with the discussion of the potential to target aberrant DNA methylation of ABC transporters for cancer therapy.<\/jats:p>","DOI":"10.3390\/cells9102281","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T21:42:21Z","timestamp":1602798141000},"page":"2281","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Aberrant DNA Methylation of ABC Transporters in Cancer"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2002-9727","authenticated-orcid":false,"given":"Katja","family":"Zappe","sequence":"first","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8699-674X","authenticated-orcid":false,"given":"Margit","family":"Cichna-Markl","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: An evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drup.2014.12.002","article-title":"Host effects contributing to cancer therapy resistance","volume":"19","author":"Katz","year":"2015","journal-title":"Drug Resist. Update"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrd3870","article-title":"The role of tumour-stromal interactions in modifying drug response: Challenges and opportunities","volume":"12","author":"McMillin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: An overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: Role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: More than just drug efflux pumps","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbagen.2018.09.019","article-title":"ABC transporters as cancer drivers: Potential functions in cancer development","volume":"1863","author":"Domenichini","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semcancer.2019.08.006","article-title":"Role of ATP-binding cassette transporters in cancer initiation and progression","volume":"60","author":"Nobili","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2013.00119","article-title":"The role of cholesterol metabolism and cholesterol transport in carcinogenesis: A review of scientific findings, relevant to future cancer therapeutics","volume":"4","author":"Cruz","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tem.2013.01.006","article-title":"Role of ABC transporters in lipid transport and human disease","volume":"24","author":"Tarling","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105377","DOI":"10.1016\/j.jsbmb.2019.105377","article-title":"Role of cholesterol homeostasis and its efflux pathways in cancer progression","volume":"191","author":"Sharma","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2019.10.004","article-title":"The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer","volume":"60","author":"Pasello","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome\u2013biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2012.06.008","article-title":"Cancer genetics and epigenetics: Two sides of the same coin?","volume":"22","author":"You","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3349\/ymj.2009.50.4.455","article-title":"Epigenetic cross-talk between DNA methylation and histone modifications in human cancers","volume":"50","author":"Kondo","year":"2009","journal-title":"Yonsei Med. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.molcel.2016.05.004","article-title":"Greater than the sum of parts: Complexity of the dynamic epigenome","volume":"62","author":"Soshnev","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00439-013-1373-5","article-title":"Cancer genomics identifies disrupted epigenetic genes","volume":"133","author":"Esteller","year":"2014","journal-title":"Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/epi.09.33","article-title":"DNA hypomethylation in cancer cells","volume":"1","author":"Ehrlich","year":"2009","journal-title":"Epigenomics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.devcel.2010.10.005","article-title":"Aberrant epigenetic landscape in cancer: How cellular identity goes awry","volume":"19","author":"Berdasco","year":"2010","journal-title":"Dev. Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.45.120403.095832","article-title":"Aberrant DNA methylation as a cancer-inducing mechanism","volume":"45","author":"Esteller","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"Borst","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12703\/P7-14","article-title":"Structure and mechanism of ABC transporters","volume":"7","author":"Wilkens","year":"2015","journal-title":"F1000Prime Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.sbi.2007.07.003","article-title":"Structure and mechanism of ABC transporter proteins","volume":"17","author":"Hollenstein","year":"2007","journal-title":"Curr. Opin. Struc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.184901","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrm2646","article-title":"ABC transporters: The power to change","volume":"10","author":"Rees","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_32","unstructured":"(2020, August 24). HUGO Gene Nomeclature Committee. Available online: https:\/\/www.genenames.org\/data\/genegroup\/#!\/group\/417."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14622416.9.1.105","article-title":"ABC multidrug transporters: Structure, function and role in chemoresistance","volume":"9","author":"Sharom","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","article-title":"Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition","volume":"38","author":"Zhou","year":"2008","journal-title":"Xenobiotica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: An overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.3748\/wjg.v24.i29.3222","article-title":"ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?","volume":"24","author":"Adamska","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tibs.2009.07.009","article-title":"Understanding polyspecificity of multidrug ABC transporters: Closing in on the gaps in ABCB1","volume":"35","author":"Gutmann","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.acr.2014.10.003","article-title":"Molecular basis of the polyspecificity of P-glycoprotein (ABCB1). Recent biochemical and structural studies","volume":"125","author":"Chufan","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","article-title":"P-glycoprotein: From genomics to mechanism","volume":"22","author":"Ambudkar","year":"2003","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.placenta.2005.05.007","article-title":"Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation","volume":"27","author":"Sun","year":"2006","journal-title":"Placenta"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1208\/aapsj070101","article-title":"Characterization of the human MDR1 gene","volume":"7","author":"Bodor","year":"2005","journal-title":"AAPS J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FPC.0b013e3283385a1c","article-title":"Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)","volume":"21","author":"Hodges","year":"2011","journal-title":"Pharm. Genom."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0021-9258(19)40260-3","article-title":"Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins","volume":"265","author":"Chen","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V74.4.1388.1388","article-title":"Expression of the mdr-1\/P-170 gene in patients with acute lymphoblastic leukemia","volume":"74","author":"Rothenberg","year":"1989","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1158\/1078-0432.CCR-03-0517","article-title":"Activation of the MDR1 upstream promoter in breast carcinoma as a surrogate for metastatic invasion","volume":"10","author":"Raguz","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"27948","DOI":"10.1074\/jbc.M313920200","article-title":"Human CCAAT\/enhancer-binding protein \u03b2 gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1038\/sj.onc.1206950","article-title":"Transcriptional regulation of ABC drug transporters","volume":"22","author":"Scotto","year":"2003","journal-title":"Oncogene"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.tpj.6500403","article-title":"Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex","volume":"7","author":"Haenisch","year":"2007","journal-title":"Pharmacogenomics J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2133\/dmpk.DMPK-11-RV-098","article-title":"Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2)","volume":"27","author":"Ieiri","year":"2012","journal-title":"Drug Metab. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.fpc.0000178311.02878.83","article-title":"Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability","volume":"15","author":"Wang","year":"2005","journal-title":"Pharmacol. Genom."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00008571-200308000-00006","article-title":"Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene","volume":"13","author":"Kroetz","year":"2003","journal-title":"Pharmacogenetics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/81.2.116","article-title":"Expression of a multidrug resistance gene in human cancers","volume":"81","author":"Goldstein","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0959-8049(96)00100-1","article-title":"MDR1 gene expression in solid tumours","volume":"32A","author":"Goldstein","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1440-1681.12581","article-title":"Molecular mechanisms for tumour resistance to chemotherapy","volume":"43","author":"Pan","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41467-019-09312-9","article-title":"Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer","volume":"10","author":"Christie","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Gomes, B.C., Honrado, M., Armada, A., Viveiros, M., Rueff, J., and Rodrigues, A.S. (2020). ABC efflux transporters and the circuitry of miRNAs: Kinetics of expression in cancer drug resistance. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082985"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00424-006-0160-8","article-title":"Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1\/ABCC1)","volume":"453","author":"Bakos","year":"2007","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"30880","DOI":"10.1074\/jbc.R114.609248","article-title":"Multidrug resistance protein 1 (MRP1, ABCC1), a \"multitasking\" ATP-binding cassette (ABC) transporter","volume":"289","author":"Cole","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2174\/0929867324666161118130238","article-title":"MRP1-dependent collateral sensitivity of multidrug-resistant cancer cells: Identifying selective modulators inducing cellular glutathione depletion","volume":"24","author":"Lorendeau","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03602532.2014.901348","article-title":"Importance of ABCC1 for cancer therapy and prognosis","volume":"46","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/092986711794839197","article-title":"Structural and functional properties of human multidrug resistance protein 1 (MRP1\/ABCC1)","volume":"18","author":"He","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pharmtox-011613-135959","article-title":"Targeting multidrug resistance protein 1 (MRP1, ABCC1): Past, present, and future","volume":"54","author":"Cole","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10915810600746023","article-title":"Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters","volume":"25","author":"Choudhuri","year":"2006","journal-title":"Int. J. Toxicol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.fpc.0000173484.51807.48","article-title":"Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1\/ABCC1)","volume":"15","author":"Deeley","year":"2005","journal-title":"Pharm. Genom"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/15216540701736285","article-title":"Role of the MRP1\/ABCC1 multidrug transporter protein in cancer","volume":"59","author":"Munoz","year":"2007","journal-title":"IUBMB Life"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.1021\/bi0503807","article-title":"Oligomerization of the human ABC transporter ABCG2: Evaluation of the native protein and chimeric dimers","volume":"44","author":"Bhatia","year":"2005","journal-title":"Biochemistry"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"15534","DOI":"10.1038\/s41598-017-15452-z","article-title":"Structure-function relationships in ABCG2: Insights from molecular dynamics simulations and molecular docking studies","volume":"7","author":"Ferreira","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00204-014-1224-8","article-title":"Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics","volume":"88","author":"Jani","year":"2014","journal-title":"Arch. Toxicol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1042\/BCJ20170923","article-title":"Residues contributing to drug transport by ABCG2 are localised to multiple drug-binding pockets","volume":"475","author":"Cox","year":"2018","journal-title":"Biochem. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2005.04.024","article-title":"Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues","volume":"235","author":"Fetsch","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0167-4781(01)00270-6","article-title":"Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene","volume":"1520","author":"Hassel","year":"2001","journal-title":"Biochim. Biophys. Acta Gene Struct. Expr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/0008-5472.CAN-03-3583","article-title":"Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene","volume":"64","author":"Ee","year":"2004","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1124\/dmd.118.083030","article-title":"Polymorphisms of the multidrug pump ABCG2: A systematic review of their effect on protein expression, function, and drug pharmacokinetics","volume":"46","author":"Heyes","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1023\/B:PHAM.0000045245.21637.d4","article-title":"Functional analysis of SNPs variants of BCRP\/ABCG2","volume":"21","author":"Kondo","year":"2004","journal-title":"Pharm. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5732\/cjc.011.10320","article-title":"Breast cancer resistance protein (BCRP\/ABCG2): Its role in multidrug resistance and regulation of its gene expression","volume":"31","author":"Nakanishi","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/dmd.118.086181","article-title":"Coexpression of ABCB1 and ABCG2 in a cell line model reveals both independent and additive transporter function","volume":"47","author":"Robinson","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10059-013-0191-x","article-title":"Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype","volume":"36","author":"Yang","year":"2013","journal-title":"Mol. Cells"},{"key":"ref_78","first-page":"1","article-title":"Human ABCG2: Structure, function, and its role in multidrug resistance","volume":"3","author":"Mo","year":"2012","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/ijc.31741","article-title":"Characterization of the breast cancer resistance protein (BCRP\/ABCG2) in clear cell renal cell carcinoma","volume":"143","author":"Reustle","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.onc.1210200","article-title":"Targeted therapy for cancer stem cells: The patched pathway and ABC transporters","volume":"26","author":"Lou","year":"2007","journal-title":"Oncogene"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fonc.2020.00764","article-title":"Cancer stem cells as a potential target to overcome multidrug resistance","volume":"10","author":"Cho","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.0400067101","article-title":"A distinct \"side population\" of cells with high drug efflux capacity in human tumor cells","volume":"101","author":"Foster","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/aps.2013.27","article-title":"Understanding and targeting cancer stem cells: Therapeutic implications and challenges","volume":"34","author":"Chen","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"165424","DOI":"10.1016\/j.bbadis.2019.02.019","article-title":"Cancer cells stemness: A doorstep to targeted therapy","volume":"1866","author":"Prasad","year":"2020","journal-title":"BBA Mol. Basis Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1006\/bbrc.2000.4219","article-title":"Apolipoprotein specificity for lipid efflux by the human ABCAI transporter","volume":"280","author":"Remaley","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"27584","DOI":"10.1074\/jbc.M103264200","article-title":"Cellular localization and trafficking of the human ABCA1 transporter","volume":"276","author":"Neufeld","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/j.1742-4658.2011.08170.x","article-title":"Function and regulation of ABCA1 \u2013 Membrane meso-domain organization and reorganization","volume":"278","author":"Nagao","year":"2011","journal-title":"FEBS J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.97.14.7987","article-title":"Complete genomic sequence of the human ABCA1 gene: Analysis of the human and mouse ATP-binding cassette A promoter","volume":"97","author":"Peterson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2741\/4692","article-title":"Epigenetic regulation of genes involved in the reverse cholesterol transport through interaction with miRNAs","volume":"23","author":"Zaiou","year":"2018","journal-title":"Front. Biosci. Landmrk"},{"key":"ref_91","first-page":"1869","article-title":"Expression of LXR-\u03b2, ABCA1 and ABCG1 in human triple-negative breast cancer tissues","volume":"42","author":"Pan","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jnci\/dju149","article-title":"ABCA transporter gene expression and poor outcome in epithelial ovarian cancer","volume":"106","author":"Hedditch","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Demidenko, R., Razanauskas, D., Daniunaite, K., Lazutka, J.R., Jankevicius, F., and Jarmalaite, S. (2015). Frequent down-regulation of ABC transporter genes in prostate cancer. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1689-8"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1208\/s12248-017-0165-6","article-title":"ABCB6, an ABC transporter impacting drug response and disease","volume":"20","author":"Fukuda","year":"2018","journal-title":"AAPS J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1007\/s00018-019-03105-5","article-title":"The human ABCB6 protein is the functional homologue of HMT-1 proteins mediating cadmium detoxification","volume":"76","author":"Kucsma","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-4781(01)00340-2","article-title":"Isolation of a genomic clone containing the promoter region of the human ATP binding cassette (ABC) transporter, ABCB6","volume":"1574","author":"Zhang","year":"2002","journal-title":"Biochim. Biophys. Acta Gene Struct. Expr."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.molonc.2011.07.005","article-title":"Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma","volume":"5","author":"Polireddy","year":"2011","journal-title":"Mol. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/323704","article-title":"A spectrum of ABCC6 mutations is responsible for Pseudoxanthoma elasticum","volume":"69","author":"Beck","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_99","first-page":"6172","article-title":"Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6)","volume":"62","author":"Belinsky","year":"2002","journal-title":"Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1038\/s41598-018-24370-7","article-title":"Persistence of the ABCC6 genes and the emergence of the bony skeleton in vertebrates","volume":"8","author":"Parreira","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_101","first-page":"289","article-title":"The molecular and physiological roles of ABCC6: More than meets the eye","volume":"3","author":"Martin","year":"2012","journal-title":"Front. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Hosen, M.J., Zubaer, A., Thapa, S., Khadka, B., De Paepe, A., and Vanakker, O.M. (2014). Molecular docking simulations provide insights in the substrate binding sites and possible substrates of the ABCC6 transporter. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102779"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.jid.5700065","article-title":"Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene","volume":"126","author":"Jiang","year":"2006","journal-title":"J. Investig. Derm."},{"key":"ref_104","first-page":"27","article-title":"Transcriptional regulation of the ABCC6 gene and the background of impaired function of missense disease-causing mutations","volume":"4","author":"Bacquet","year":"2013","journal-title":"Front. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"6786245","DOI":"10.1155\/2016\/6786245","article-title":"ABC transporter subfamily D: Distinct differences in behavior between ABCD1-3 and ABCD4 in subcellular localization, function, and human disease","volume":"2016","author":"Kawaguchi","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/j.1476-5381.2011.01435.x","article-title":"Mammalian peroxisomal ABC transporters: From endogenous substrates to pathology and clinical significance","volume":"164","author":"Kemp","year":"2011","journal-title":"Brit. J. Pharm."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/8904_2018_118","article-title":"Stability of the ABCD1 protein with a missense mutation: A novel approach to finding therapeutic compounds for X-linked adrenoleukodystrophy","volume":"44","author":"Morita","year":"2018","journal-title":"JIMD Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1042\/BST20150114","article-title":"Role of family D ATP-binding cassette transporters (ABCD) in cancer","volume":"43","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"48275","DOI":"10.1074\/jbc.M310223200","article-title":"ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion","volume":"278","author":"Graf","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1194\/jlr.R084244","article-title":"ABCG5 and ABCG8: More than a defense against xenosterols","volume":"59","author":"Patel","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI0216001","article-title":"Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol","volume":"110","author":"Yu","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00424-005-0040-7","article-title":"Sterolins ABCG5 and ABCG8: Regulators of whole body dietary sterols","volume":"453","author":"Hazard","year":"2007","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1194\/jlr.C400002-JLR200","article-title":"The orphan nuclear receptor LRH-1 activates the ABCG5\/ABCG8 intergenic promoter","volume":"45","author":"Freeman","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","article-title":"Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters","volume":"290","author":"Berge","year":"2000","journal-title":"Science"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.bbagen.2009.02.001","article-title":"Hunting for the 5th base: Techniques for analyzing DNA methylation","volume":"1790","author":"Ammerpohl","year":"2009","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_116","first-page":"71","article-title":"Combined bisulfite restriction analysis (COBRA)","volume":"200","author":"Eads","year":"2002","journal-title":"Methods Mol. Biol. (Clifton N.J.)"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1038\/nprot.2006.324","article-title":"DNA methylation: Bisulphite modification and analysis","volume":"1","author":"Clark","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1373\/clinchem.2008.121962","article-title":"PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment","volume":"55","author":"Kristensen","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/nprot.2008.191","article-title":"Methylation-sensitive high-resolution melting","volume":"3","author":"Wojdacz","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/nprot.2007.314","article-title":"DNA methylation analysis by pyrosequencing","volume":"2","author":"Tost","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-61779-316-5_2","article-title":"DNA methylation detection: Bisulfite genomic sequencing analysis","volume":"791","author":"Li","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13059-016-1066-1","article-title":"Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling","volume":"17","author":"Pidsley","year":"2016","journal-title":"Genome Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2217\/epi.10.32","article-title":"The implications of heterogeneous DNA methylation for the accurate quantification of methylation","volume":"2","author":"Mikeska","year":"2010","journal-title":"Epigenomics"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-10-3394","article-title":"Analysis of promoter CpG island hypermethylation in cancer: Location, location, location!","volume":"17","author":"Niessen","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/ijc.23149","article-title":"Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer","volume":"122","author":"Raguz","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF02673749","article-title":"Demethylation of the human MDR1 5\u2032 region accompanies activation of P-glycoprotein expression in a HL60 multidrug resistant subline","volume":"23","author":"Desiderato","year":"1997","journal-title":"Somat. Cell Mol. Genet."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1038\/sj.onc.1208955","article-title":"Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs","volume":"24","author":"Baker","year":"2005","journal-title":"Oncogene"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/MCB.22.6.1844-1857.2002","article-title":"Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation","volume":"22","author":"Kantharidis","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4161\/cbt.3.6.845","article-title":"MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: Changes in chromatin structure induced by treatment with 5-aza-cytidine","volume":"3","author":"David","year":"2004","journal-title":"Cancer Biol. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4161\/epi.3.5.6868","article-title":"Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells","volume":"3","author":"Reed","year":"2008","journal-title":"Epigenetics"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/tpj.2010.1","article-title":"The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance","volume":"10","author":"Reed","year":"2010","journal-title":"Pharmacogenomics J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/iep.12212","article-title":"Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line","volume":"97","author":"Li","year":"2017","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2020.03.114","article-title":"Genetic and epigenetic aberrations of ABCB1 synergistically boost the acquisition of taxane resistance in esophageal squamous cancer cells","volume":"526","author":"Sumarpo","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_134","first-page":"265","article-title":"Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer","volume":"27","author":"Chen","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.leukres.2014.06.001","article-title":"Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line","volume":"38","author":"Moreira","year":"2014","journal-title":"Leuk. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1158\/0008-5472.CAN-04-0081","article-title":"CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer","volume":"64","author":"Enokida","year":"2004","journal-title":"Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Henrique, R., Oliveira, A.I., Costa, V.L., Baptista, T., Martins, A.T., Morais, A., Oliveira, J., and Jer\u00f3nimo, C. (2013). Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-898"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1476-4598-9-68","article-title":"DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response","volume":"9","author":"Dejeux","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_139","first-page":"763","article-title":"Development of high-resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma","volume":"42","author":"Vaclavikova","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Klajic, J., Fleischer, T., Dejeux, E., Edvardsen, H., Warnberg, F., Bukholm, I., L\u00f8nning, P.E., Solvang, H., B\u00f8rresen-Dale, A.L., and Tost, J. (2013). Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-456"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/bcr2466","article-title":"Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer","volume":"12","author":"Muggerud","year":"2010","journal-title":"Breast Cancer Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"73347","DOI":"10.18632\/oncotarget.12332","article-title":"Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients","volume":"7","author":"Spitzwieser","year":"2016","journal-title":"Oncotarget"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2015.02.049","article-title":"Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance","volume":"361","author":"Miklos","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Oberstadt, M.C., Bien-M\u00f6ller, S., Weitmann, K., Herzog, S., Hentschel, K., Rimmbach, C., Vogelgesang, S., Balz, E., Fink, M., and Michael, H. (2013). Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-617"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/cncr.23285","article-title":"Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells","volume":"112","author":"Nakano","year":"2008","journal-title":"Cancer"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1128\/MCB.00650-06","article-title":"Aberrant promoter methylation of the ABCG2 gene in renal carcinoma","volume":"26","author":"To","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1593\/neo.91314","article-title":"Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance","volume":"11","author":"Bram","year":"2009","journal-title":"Neoplasia"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3892\/or.2015.4342","article-title":"Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines","volume":"35","author":"Moon","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1182\/blood-2005-10-009084","article-title":"ABCG2 expression, function, and promoter methylation in human multiple myeloma","volume":"108","author":"Turner","year":"2006","journal-title":"Blood"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1002\/cncr.24369","article-title":"Promoter methylation of glutathione S-transferase \u03c01 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression","volume":"115","author":"Gao","year":"2009","journal-title":"Cancer"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canlet.2005.01.038","article-title":"Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells","volume":"231","author":"Chekhun","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clinbiochem.2009.10.009","article-title":"CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients","volume":"43","author":"Sharma","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12935-019-0770-9","article-title":"Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: A study based on the Cancer Genome Atlas","volume":"19","author":"Lu","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_154","first-page":"337","article-title":"Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis","volume":"29","author":"Tahara","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/2211-5463.12765","article-title":"Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein\u2013Barr virus-associated gastric cancer","volume":"10","author":"Ohmura","year":"2020","journal-title":"FEBS Open Bio"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3892\/ijo.2013.1854","article-title":"ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma","volume":"42","author":"Tsunedomi","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_157","first-page":"4618","article-title":"MRD1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment","volume":"6","author":"Tada","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1158\/1078-0432.CCR-07-0861","article-title":"A novel set of DNA methylation markers in urine sediments for sensitive\/specific detection of bladder cancer","volume":"13","author":"Yu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1158\/0008-5472.CAN-03-3972","article-title":"Hypermethylation of CpG islands in primary and metastatic human prostate cancer","volume":"64","author":"Yegnasubramanian","year":"2004","journal-title":"Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.juro.2007.09.038","article-title":"CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer","volume":"179","author":"Bastian","year":"2008","journal-title":"J. Urol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11010-010-0426-5","article-title":"Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1","volume":"340","author":"Liu","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1158\/0008-5472.CAN-12-3128","article-title":"Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1","volume":"73","author":"Lee","year":"2013","journal-title":"Cancer Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/15592294.2015.1022019","article-title":"Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men","volume":"10","author":"Devaney","year":"2015","journal-title":"Epigenetics"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-014-0036-2","article-title":"Hypermethylation of the TGF-\u03b2 target, ABCA1 is associated with poor prognosis in ovarian cancer patients","volume":"7","author":"Chou","year":"2015","journal-title":"Clin. Epigenet."},{"key":"ref_165","first-page":"2025","article-title":"Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance","volume":"3","author":"Kantharidis","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood.V92.11.4296","article-title":"Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias","volume":"92","author":"Nakayama","year":"1998","journal-title":"Blood"},{"key":"ref_167","first-page":"a009514","article-title":"Cystic fibrosis transmembrane conductance regulator (ABCC7) structure","volume":"3","author":"Hunt","year":"2013","journal-title":"CSH Perspect Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.biotechadv.2013.06.004","article-title":"Different strategies to overcome multidrug resistance in cancer","volume":"31","author":"Saraswathy","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejmech.2017.07.062","article-title":"Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents","volume":"142","author":"Beretta","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/07388551.2015.1015957","article-title":"Molecular mechanisms of drug resistance and its reversal in cancer","volume":"36","author":"Baran","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/14728222.2017.1310841","article-title":"The therapeutic potential of targeting ABC transporters to combat multi-drug resistance","volume":"21","author":"Bugde","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1517\/13543784.2012.679339","article-title":"Investigational ABC transporter inhibitors","volume":"21","author":"Falasca","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fonc.2014.00002","article-title":"Small and innovative molecules as new strategy to revert MDR","volume":"4","author":"Zinzi","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li","year":"2016","journal-title":"Drug Resist. Update"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/med.21510","article-title":"Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: A historic approach and recent advances","volume":"39","author":"Stefan","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fphar.2019.00208","article-title":"Inhibitors of human ABCG2: From technical background to recent updates with clinical implications","volume":"10","author":"Toyoda","year":"2019","journal-title":"Front. Pharm."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/med.21428","article-title":"ABCG2\/BCRP: Specific and nonspecific modulators","volume":"37","author":"Stark","year":"2017","journal-title":"Med. Res. Rev."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"228","DOI":"10.20892\/j.issn.2095-3941.2017.0052","article-title":"Recent progress on nanoparticle-based drug delivery systems for cancer therapy","volume":"14","author":"Xin","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41598-018-19325-x","article-title":"Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells","volume":"8","author":"Nanayakkara","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbpa.2018.03.003","article-title":"Epigenetic small molecule modulators of histone and DNA methylation","volume":"45","author":"Hauser","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-med-111314-035900","article-title":"Epigenetic therapeutics: A new weapon in the war against cancer","volume":"67","author":"Ahuja","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15592294.2019.1640546","article-title":"Epidrugs: Targeting epigenetic marks in cancer treatment","volume":"14","author":"Furtado","year":"2019","journal-title":"Epigenetics"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13148-017-0319-5","article-title":"Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma","volume":"9","author":"Issa","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fgene.2019.00514","article-title":"Curcumin as an alternative epigenetic modulator: Mechanism of action and potential effects","volume":"10","author":"Hassan","year":"2019","journal-title":"Front. Genet."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Arora, I., Sharma, M., and Tollefsbol, T.O. (2019). Combinatorial epigenetics impact of polyphenols and phytochemicals in cancer prevention and therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184567"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1182\/blood-2013-04-427724","article-title":"Perspectives and future directions for epigenetics in hematology","volume":"121","author":"Goodell","year":"2013","journal-title":"Blood"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cbpa.2020.04.008","article-title":"Towards a more precise therapy in cancer: Exploring epigenetic complexity","volume":"57","author":"Esteller","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: Mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1158\/0008-5472.CAN-13-3553","article-title":"Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-like cells","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/bjc.2013.188","article-title":"Melatonin-induced methylation of the ABCG2\/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells","volume":"108","author":"Herrera","year":"2013","journal-title":"Br. J. Cancer"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/10\/2281\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:20:23Z","timestamp":1760178023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/10\/2281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":191,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["cells9102281"],"URL":"https:\/\/doi.org\/10.3390\/cells9102281","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}